Tata Consultancy Services’ Connected Clinical Trials Platform, Part of the Advanced Drug Development (ADD) Suite, Received the Recognition for its Thoughtful Approach to Solving Tough Industry Problems
BARCELONA | MUMBAI, September 27, 2019: Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS), a leading global IT services, consulting, and business solutions organization, announced that its Connected Clinical Trials (CCT) platform has won the 2019 European Innovations Award at the Summit for Clinical Operations Executives (SCOPE) – Europe.
Clinical Research News’ European Innovations Awards recognize outstanding examples of applied strategic innovation - partnerships, deployments, and collaborations that manifestly improve the clinical trial process. CCT was recognized for its thoughtful approach to solving tough industry problems, its ability to provide quantifiable returns on investment and ease of deployment.
“TCS is focused on harnessing the power of digital technologies to transform the drug development value chain in the life sciences industry, creating innovative solutions that deliver greater value for our customers and superior patient outcomes,” said Debashis Ghosh, Global Head, Life Sciences and Healthcare, TCS. “Our CCT platform encompasses the complete clinical trials ecosystem and helps sponsors achieve enhanced patient engagement, ensure better adherence to test protocols, and achieve greater transparency, efficiency, and compliance with regulatory guidelines.”
“These awards celebrate dedication and innovation in clinical research, and the winners chosen highlight the inspiring work being done in the industry. The research community in Europe is increasingly open, and the projects showcased in this year's award program prove their dedication to excellence," said Allison Proffitt, Editorial Director, Clinical Research News. "We were particularly pleased with this year’s entries. The winners represented some of the best innovation in clinical research, and the judges and I were thrilled with the caliber of solutions from Tata Consultancy Services."
An innovative Software-as-a-Service (SaaS) platform, CCT connects patients, sites, and sponsors and leverages sensors, smart packages, and mobile devices and apps to enable real-time data integration, analytics and tailored patient support. It provides end-to-end visibility on how clinical supplies are managed, both on site and at the patients’ homes, and significantly transforms patient engagement in clinical trials.
CCT is part of TCS’ Advanced Drug Development (ADD) suite that leverages the power of Artificial Intelligence by offering a wide range of cloud-based clinical solutions and services in the areas of clinical data management, metadata management, pharmacovigilance, and data analytics and insights.
About Tata Consultancy Services Ltd. (TCS)
Tata Consultancy Services is an IT services, consulting and business solutions organization that has been partnering with many of the world’s largest businesses in their transformation journeys for the last fifty years. TCS offers a consulting-led, cognitive powered, integrated portfolio of business, technology and engineering services and solutions. This is delivered through its unique Location Independent Agile delivery model, recognized as a benchmark of excellence in software development.
A part of the Tata group, India's largest multinational business group, TCS has over 436,000 of the world’s best-trained consultants in 46 countries. The company generated consolidated revenues of US $20.9 billion in the fiscal year ended March 31, 2019, and is listed on the BSE (formerly Bombay Stock Exchange) and the NSE (National Stock Exchange) in India. TCS' proactive stance on climate change and award winning work with communities across the world have earned it a place in leading sustainability indices such as the Dow Jones Sustainability Index (DJSI), MSCI Global Sustainability Index and the FTSE4Good Emerging Index. For more information, visit us at www.tcs.com .
To stay up-to-date on TCS global news, follow @TCS_News.
TCS Media Contacts
Phone: +65 9138 4370
Phone: +61 422 989 682
Phone: +31 615 903387
Phone: +1 647 790 7602
Phone: +49 172 6615789
Phone: +91 22 6778 9960
Phone: +81 80 2115 0989
Phone: +569 6170 9013
Phone: +44 20 3155 2421
Phone: +1 646 313 4594